17
Aug 2021
Terminal bowel cancer patients offered new hope thanks to breakthrough drug combination to be offered on the NHS
Clinical trials of the new drug combination found more than 50 per cent of patients given the treatment, who had all failed to respond to standard radiotherapy and chemotherapy treatment, were still alive five years later. Professor John Bridgewater, consultant oncologist at University College Hospital in London, said many of the patients that took…